7 pharmaceutical companies to spend more than KRW 50 billion into R&D

Among listed pharmaceutical companies, there were 7 companies which invested more than KRW 50 billion into R&D expenses last year, including Hanmi Pharm and Green Cross.

Moreover, although many companies seem to actively focus on R&D as inspired by exports of new pharmaceutical technology achieved by pharmaceutical companies such as Hanmi Pharm, their R&D investments were actually been analyze...